Evidence map›Paper›PMID 34505226›Full record

ArticleInternational urology and nephrology2022

Arterial calcifications and osteoprotegerin in chronic hemodialysis patients: impact on 6-year survival.

Diana Moldovan, Crina Rusu, Alina Potra, Cosmina Bondor, Maria Ticala, Dacian Tirinescu, Anca Coman, Olga Orasan, Ioan Moldovan, Remus Orasan and 1 more

Abstract read
PubMed Publisher
In one paragraph

Article in International urology and nephrology, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Osteoprotegerin: A Biomarker in Chronic Kidney Disease.Arquivos brasileiros de cardiologia · 2024
    Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Diana MoldovanDepartment of Nephrology, University of Medicine and Pharmacy "Iuliu Haţieganu", Cluj-Napoca, Romania. dnmoldovan@yahoo.com.ORCID http://orcid.org/0000-0001-5463-5317
Crina RusuDepartment of Nephrology, University of Medicine and Pharmacy "Iuliu Haţieganu", Cluj-Napoca, Romania.
Alina PotraDepartment of Nephrology, University of Medicine and Pharmacy "Iuliu Haţieganu", Cluj-Napoca, Romania.
Cosmina BondorDepartment of Statistics, University of Medicine and Pharmacy "Iuliu Haţieganu", Cluj-Napoca, Romania.
Maria TicalaDepartment of Nephrology, University of Medicine and Pharmacy "Iuliu Haţieganu", Cluj-Napoca, Romania.
Dacian TirinescuDepartment of Nephrology, University of Medicine and Pharmacy "Iuliu Haţieganu", Cluj-Napoca, Romania.
Anca ComanDepartment of Nephrology, University of Medicine and Pharmacy "Iuliu Haţieganu", Cluj-Napoca, Romania.
Olga Orasan4th Medical Department, University of Medicine and Pharmacy "Iuliu Haţieganu", Cluj-Napoca, Romania.
Ioan MoldovanEmergency Military Hospital, Cluj-Napoca, Romania.
Remus OrasanNefromed Dialysis Center, Cluj-Napoca, Romania.
Ina KacsoDepartment of Nephrology, University of Medicine and Pharmacy "Iuliu Haţieganu", Cluj-Napoca, Romania.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimThe association between end-stage renal disease and cardiovascular mortality may be influenced through vascular alterations, in particular atherosclerosis and vascular calcification. The study goal was to assess the impact of each type of arterial intimal calcifications (AIC) and arterial medial calcifications (AMC), of osteoprotegerin (OPG), mineral metabolism markers and other features on all-cause and cardiovascular mortality in chronic hemodialysis patients.

methodsUltrasound was performed in 87 patients on the carotid and femoral arteries, and the severity of AIC and AMC was assessed calculating a score according to the extension of calcification. We analyzed the link between AIC, AMC, OPG, mineral markers and mortality after 6 years of follow-up.

resultsThe cutoff value for OPG determined using ROC was 4.9 pmol/l for all-cause and cardiovascular mortality. Patients with higher serum OPG levels presented higher mortality rates. Our study revealed that AIC, high OPG, low ankle-arm index, presence of diabetes, smoking status, and lack of arteriovenous fistula are associated with all-cause and cardiovascular mortality in univariate regression analysis. Multivariate analysis identified AIC scoring based on the segmentation method as an independent predictor of all-cause and cardiovascular mortality, along with increased OPG levels. AMC scoring was not a predictor of mortality.

conclusionsIdentifying and scoring AIC on ultrasound and measuring OPG levels, as a basis of the HD patient assessment may become valuable tools in clinical work, as these have an impact on death toll.

Indexed as

AtherosclerosisKidney Failure, ChronicVascular CalcificationBiomarkersHumansOsteoprotegerinRenal DialysisBiomarkersOsteoprotegerinArterial calcificationHemodialysis patientsOsteoprotegerinSurvival

Identifiers

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.